FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:792-793 September 11, 1997 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article

To the Editor: Miller and Panosian (May 1 issue)¹ report an association between artesunate and a post-treatment cerebellar syndrome in falciparum malaria. As they state, no overt neurotoxicity has been reported in over a million patients with malaria who were treated with artemisinin derivatives. We treated two patients who had undergone splenectomy with prolonged courses of artesunate, artemisinin, or both to achieve parasite clearance (total doses, 165 mg per kilogram of body weight and 46 mg per kilogram over periods of 12 and 11 days, respectively), without neurotoxicity in either.² Postmortem examination of the brain stem from another patient with . . . [Full Text of this Article]

References

Related Letters:

Ataxia and Slurred Speech after Artesunate Treatment for Falciparum Malaria
Miller L. G., Panosian C. B.
Extract | Full Text  
N Engl J Med 1997; 336:1328-1329, May 1, 1997. Correspondence

This article has been cited by other articles:

• Si, Y., Li, Q., Xie, L., Bennett, K., Weina, P. J., Mog, S., Johnson, T. O. (2007). Neurotoxicity and Toxicokinetics of Artelinic Acid Following Repeated Oral Administration in Rats. International Journal of Toxicology 26: 401-410 [Abstract] [Full Text]